Inogen Appoints Reding to New COO Role

Dow Jones
07/02
 

Inogen appointed Andy Reding to a newly created chief operating officer position, effective July 6.

Reding most recently served as chief commercial officer at Viant Medical, and previously served as vice president and general manager of Hillrom Respiratory Health.

He will receive an annual base salary of $500,000, a sign-on cash bonus of $100,000, and an equity award of 130,000 shares which will vest over three years, plus other bonuses and benefits, the medical technology company said.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

July 01, 2026 16:21 ET (20:21 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10